{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:03:48Z","timestamp":1790085828510,"version":"4.0.1"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Exosomes have emerged as important mediators in the pathophysiology of hypertension, facilitating intercellular communication through the transfer of bioactive molecules such as microRNAs. This review synthesizes current evidence on the multifaceted roles of exosomes in hypertensive vascular damage, highlighting their involvement in endothelial dysfunction, vascular smooth muscle cell phenotypic switching, renin\u2013angiotensin\u2013aldosterone system modulation, and renal ion transport regulation. Circulating exosomal microRNAs are identified as central drivers of inflammation and vascular remodeling, while urinary exosomes offer non-invasive insights into renal sodium handling and early hypertensive injury. Conversely, mesenchymal stem cell-derived exosomes demonstrate considerable vasoprotective and immunomodulatory properties, positioning them as therapeutic candidates. We further discuss emerging engineering strategies, both endogenous and exogenous, that aim to enhance exosomal targeting, cargo delivery, and therapeutic efficacy. Despite progress, challenges related to biological heterogeneity and long-term safety remain barriers to clinical translation. This review underscores the dual potential of exosomes as diagnostic biomarkers and therapeutic platforms, while outlining directions for future research toward clinical implementation in hypertension management.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1830650","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:29:50Z","timestamp":1790083790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomes in hypertension: mechanisms, biomarkers, and therapeutic opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Dexiu","family":"Li","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyue","family":"Ma","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital of Clinical Medical College of Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Qiu","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zheng","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111685","article-title":"Exosomes as intercellular messengers in hypertension","volume":"22","author":"Arishe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2021.0191","article-title":"Stem cell and exosome therapy in pulmonary hypertension","volume":"52","author":"Oh","year":"2022","journal-title":"Korean Circ J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1417758","article-title":"The role of exosomal molecular cargo in exosome biogenesis and disease diagnosis","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw054","article-title":"Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice","volume":"110","author":"Aliotta","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/01913123.2025.2493116","article-title":"Exosomes in ultrastructural resistance artery remodeling of human hypertension","volume":"49","author":"Perrotta","year":"2025","journal-title":"Ultrastruct Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12931-020-1331-4","article-title":"Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/bjbs.2025.14780","article-title":"Identification of an exosomal miRNA signature in newly diagnosed essential hypertensive adults","volume":"82","author":"Tan","year":"2025","journal-title":"Br J BioMed Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/cdt-2025-76","article-title":"Emerging exosomal biomarkers for essential hypertension: a systematic review","volume":"15","author":"Zhong","year":"2025","journal-title":"Cardiovasc Diagn Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12967-018-1604-6","article-title":"Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension","volume":"16","author":"Perez-Hernandez","year":"2018","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","article-title":"Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase","volume":"60","author":"Sun","year":"2012","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108799","article-title":"S-amlodipine improves endothelial dysfunction via the RANK\/RANKL\/OPG system by regulating microRNA-155 in hypertension","volume":"114","author":"Yang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.315428","article-title":"T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension","volume":"126","author":"Nosalski","year":"2020","journal-title":"Circ Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018020117","article-title":"MicroRNA-214-3p in the kidney contributes to the development of hypertension","volume":"29","author":"Liu","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.117","article-title":"Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension","volume":"28","author":"Kontaraki","year":"2013","journal-title":"J Hum Hypertens"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2015.1036064","article-title":"Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension","volume":"37","author":"Cengiz","year":"2015","journal-title":"Clin Exp Hypertens"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5216","article-title":"Molecular mechanisms in vascular injury induced by hypertension: expression and role of microRNA-34a","volume":"14","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00696.2024","article-title":"Involvement of microRNA-146a-5p, but not -155-5p and -29b-5p, in left ventricular remodeling and dysfunction in spontaneously hypertensive rats","volume":"328","author":"Mkhize","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-018-0061-2","article-title":"Association between hypertension and circulating vascular-related microRNAs","volume":"32","author":"Hijmans","year":"2018","journal-title":"J Hum Hypertens"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701073R","article-title":"Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p","volume":"32","author":"Bao","year":"2018","journal-title":"FASEB J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/s41467-020-18538-x","article-title":"Macrophage secretion of miR-106b-5p causes renin-dependent hypertension","volume":"11","author":"Oh","year":"2020","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ajh\/hpz112","article-title":"Secreted monocyte miR-27a, via mesenteric arterial Mas receptor-eNOS pathway, causes hypertension","volume":"33","author":"Zou","year":"2020","journal-title":"Am J Hypertens"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2016.163","article-title":"Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions","volume":"40","author":"Osada-Oka","year":"2016","journal-title":"Hypertens Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2018.0510","article-title":"Involvement of the miR-181b-5p\/HMGB1 pathway in Ang II-induced phenotypic transformation of smooth muscle cells in hypertension","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.06.075","article-title":"Plasma exosomes regulate systemic blood pressure in rats","volume":"503","author":"Otani","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11375","article-title":"Exosome-mediated transfer of ACE (angiotensin-converting enzyme) from adventitial fibroblasts of spontaneously hypertensive rats promotes vascular smooth muscle cell migration","volume":"72","author":"Tong","year":"2018","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.125.326133","article-title":"Super-enhancer-driven HCG20 promotes pulmonary hypertension through U2AF2 splicing","volume":"137","author":"Mei","year":"2025","journal-title":"Circ Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2441","article-title":"Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs","volume":"14","author":"Hergenreider","year":"2012","journal-title":"Nat Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38864","article-title":"Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster","volume":"119","author":"Boettger","year":"2009","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12265-017-9784-7","article-title":"miRNA profiling of exosomes from spontaneous hypertensive rats using next-generation sequencing","volume":"12","author":"Liu","year":"2018","journal-title":"J Cardiovasc Transl Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-014-0431-2","article-title":"Angiotensin II and vascular injury","volume":"16","author":"Montezano","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100766RR","article-title":"Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7","volume":"35","author":"Li","year":"2021","journal-title":"FASEB J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1698795","article-title":"MiR155-5p in adventitial fibroblasts-derived extracellular vesicles inhibits vascular smooth muscle cell proliferation via suppressing angiotensin-converting enzyme expression","volume":"9","author":"Ren","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2014.06.008","article-title":"Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system","volume":"75","author":"Kemp","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403453101","article-title":"Identification and proteomic profiling of exosomes in human urine","volume":"101","author":"Pisitkun","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2015010074","article-title":"Extracellular vesicles in renal diseases: more than novel biomarkers","volume":"27","author":"Erdbr\u00fcgger","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014111137","article-title":"Activation of the endogenous renin-angiotensin-aldosterone system or aldosterone administration increases urinary exosomal sodium channel excretion","volume":"27","author":"Qi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112580","article-title":"Sodium chloride cotransporter in hypertension","volume":"12","author":"Castagna","year":"2024","journal-title":"Biomedicines"},{"key":"B40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MNH.0000000000000192","article-title":"Urinary extracellular vesicles as markers to assess kidney sodium transport","volume":"25","author":"Salih","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201400198","article-title":"Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals","volume":"9","author":"Castagna","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.05.052","article-title":"Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure","volume":"46","author":"Gildea","year":"2013","journal-title":"Clin Biochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.118.11875","article-title":"MiR-192-5p in the kidney protects against the development of hypertension","volume":"73","author":"Baker","year":"2019","journal-title":"Hypertension"},{"key":"B44","doi-asserted-by":"publisher","first-page":"24117","DOI":"10.1038\/s41598-024-75080-2","article-title":"Understanding the role of soluble proteins and exosomes in non-invasive urine-based diagnosis of preeclampsia","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2020.1783869","article-title":"Stem cell-derived extracellular vesicles mitigate ageing-associated arterial stiffness and hypertension","volume":"9","author":"Feng","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2020.0132","article-title":"Exosomes protect against acute myocardial infarction in rats by regulating the renin-angiotensin system","volume":"30","author":"Xiao","year":"2021","journal-title":"Stem Cells Dev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16192","article-title":"Exosomes from microRNA-126 overexpressing mesenchymal stem cells promote angiogenesis by targeting the PIK3R2-mediated PI3K\/Akt signalling pathway","volume":"25","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-025-10612-3","article-title":"Mesenchymal stem cell-based apelin gene therapy improves pulmonary artery remodeling in monocrotaline-induced pulmonary hypertension through PI3K\/AKT\/eNOS and ERK1\/2 signaling pathways","volume":"18","author":"Wang","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxad098","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes alleviate hypoxia-induced pulmonary arterial hypertension in mice via macrophages","volume":"42","author":"Liu","year":"2024","journal-title":"Stem Cells"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115816","article-title":"Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1\/SPP1 signaling pathway","volume":"168","author":"Chen","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116382","article-title":"Mesenchymal stem cell-derived exosomes ameliorate hypoxic pulmonary hypertension by inhibiting the Hsp90aa1\/ERK\/pERK pathway","volume":"226","author":"Deng","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105564","article-title":"Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P\/SK1\/S1PR1 signaling and promoting macrophage M2 polarization","volume":"114","author":"Deng","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2013.01.002","article-title":"Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K\/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia\/reperfusion injury","volume":"10","author":"Arslan","year":"2013","journal-title":"Stem Cell Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S493047","article-title":"Tadalafil enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in pulmonary hypertension by upregulating miR-29a-3p","volume":"19","author":"Liu","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13287-024-03652-0","article-title":"Mesenchymal stem cell-derived exosomes: a promising alternative in the therapy of preeclampsia","volume":"15","author":"Shi","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2026.1704427","article-title":"Identification of circulating microRNA biomarkers in pulmonary hypertension of group 2 for early detection","volume":"13","author":"Qin","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15337","article-title":"The antagonistic effects and mechanisms of microRNA-26a action in hypertensive vascular remodelling","volume":"178","author":"Zhang","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911964","article-title":"MircoRNA in extracellular vesicles from patients with pulmonary arterial hypertension alters endothelial angiogenic response","volume":"23","author":"Khandagale","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2025.2511056","article-title":"Mechanistic study of the association between microRNA-126 and hypertension in obstructive sleep apnea-hypopnea syndrome","volume":"47","author":"Huang","year":"2025","journal-title":"Clin Exp Hypertens"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/ame2.12332","article-title":"CircPMS1 promotes proliferation of pulmonary artery smooth muscle cells, pulmonary microvascular endothelial cells, and pericytes under hypoxia","volume":"7","author":"Hu","year":"2023","journal-title":"Anim Model Exp Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00057.2017","article-title":"Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1","volume":"314","author":"Sysol","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221138550","article-title":"Dysregulated miR-222-3p in plasma exosomes of preeclampsia patients and its in vitro effect on HTR8\/SVneo extravillous trophoblast cells by targeting STMN1","volume":"41","author":"Yang","year":"2022","journal-title":"Hum Exp Toxicol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa031","article-title":"Circulating let-7g-5p and miR-191-5p are independent predictors of chronic kidney disease in hypertensive patients","volume":"33","author":"Berillo","year":"2020","journal-title":"Am J Hypertens"},{"key":"B65","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s13287-025-04546-5","article-title":"Apoptotic vesicles of mesenchymal stem cells promote M2 polarization and alleviate early-onset preeclampsia via miR-191-5p","volume":"16","author":"Li","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0708","article-title":"Therapeutic potential of nucleic acids when combined with extracellular vesicles","volume":"12","author":"Jurgielewicz","year":"2021","journal-title":"Aging Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2016-0038","article-title":"Exosomes derived from Akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D","volume":"6","author":"Ma","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","article-title":"HIF-1\u03b1 overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.4c04638","article-title":"Hypoxia-induced and glucuronic acid-modified extracellular vesicles from mesenchymal stromal cells treat pulmonary arterial hypertension by improving vascular remodeling","volume":"24","author":"Zhu","year":"2024","journal-title":"Nano Lett"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","article-title":"Current strategies for exosome cargo loading and targeting delivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"key":"B71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bioactmat.2021.06.005","article-title":"Bioinspired therapeutic platform based on extracellular vesicles for prevention of arterial wall remodeling in hypertension","volume":"8","author":"Wang","year":"2021","journal-title":"Bioact Mater"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123438","article-title":"Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment","volume":"323","author":"Kim","year":"2025","journal-title":"Biomaterials"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00410-w","article-title":"Therapeutically harnessing extracellular vesicles","volume":"21","author":"Cheng","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2017.1333882","article-title":"Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery","volume":"6","author":"Sutaria","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J Control Release"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/14686996.2022.2133342","article-title":"Advances of engineered extracellular vesicles-based therapeutics strategy","volume":"23","author":"Komuro","year":"2022","journal-title":"Sci Technol Adv Mater"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1830650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:29:51Z","timestamp":1790083791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1830650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2026.1830650"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1830650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1830650"}}